Belgian CRO genae buys an eClinical outfit

Fast-expanding CRO genae is buying into clinical trial technology, acquiring a company that focuses on electronic data capture.

genae CEO Bart Segers

The Belgian company paid an undisclosed sum for e-novex, provider of a proprietary technology for gathering trial data and allowing investigators to access it from anywhere. The company's principal offering is, a tool that puts all the forms, queries and questions involved in clinical trials in one place. E-novex also markets the complementary edc2go, designed to speed up the process of generating case report forms from clinical trial sites.

Genae plans to roll e-novex's technology and entire staff into its existing e-Solutions business, which offers data management and statistical services.

"The purchase of e-novex further increases genae's capacity to provide electronic solutions to our customers in the medical industries," CEO Bart Segers said in a statement. "The acquisition is also expected to result in greater eHealth efficiencies and in significantly increasing our capabilities in data management and risk based monitoring."

The Antwerp-headquartered CRO has been steadily expanding its global reach over the past few years, opening outposts in Germany, Switzerland, the U.K. and the U.S.

- read the statement

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.